Ataxin 2 (ATXN2) (Middle Region) Peptide
ATXN2
适用: 人
宿主: 合成
BP, WB
-
- 抗原 See all Ataxin 2 (ATXN2) products
- Ataxin 2 (ATXN2)
- 蛋白结构域
- Middle Region
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-ATXN2 antibody (Catalog #: ARP38210_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 纯化方法
- Purified
-
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 浓度
- 1 mg/mL
- 缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- Ataxin 2 (ATXN2)
- 别名
- ASL13 Peptide, ATX2 Peptide, SCA2 Peptide, TNRC13 Peptide, 9630045M23Rik Peptide, AW544490 Peptide, Sca2 Peptide, ATXN2 Peptide, MGC115230 Peptide, ataxin 2 Peptide, ataxin 2 L homeolog Peptide, ATXN2 Peptide, Atxn2 Peptide, atxn2.L Peptide
- 背景
-
The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA ty
Alias Symbols: ATX2, FLJ46772, SCA2, TNRC13
Protein Interaction Partner: A2BP1,ACTN1,ACTN2,ATXN1,BAT3,BIN1,CHGB,GFI1B,IDH3B,KIAA1279,LCP1,NCOA4,PABPC1,PLS3,SH3GL2,SH3GL3,TDRD7,ZNRD1,CD247,CHGB,VHL
Protein Size: 1313 - 分子量
- 140 kDa
- 基因ID
- 6311
- NCBI登录号
- NM_002973, NP_002964
- UniProt
- Q99700
-
You are here:
